Since the other major beneficial effect of cardiac β2AR signaling in vivo is inhibition of apoptosis (promotion of survival), we also tested the effects of cardiac GRK2 blockade in vivo on this aspect of β2AR signaling in the context of post-MI HF progression. The gene discussed is GRK2; the disease is hydrops fetalis.